A unifying hypothesis for the renin-angiotensin system and hematopoiesis: Sticking the pieces together with the JAK-STAT pathway

Medical Hypotheses

Volumn 54, Issue 1, 2000, Pages 80-83

  Haznedaro G I C ^a   Arici, M ^a   Buyukasik Y ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ELECTROLYTE; GROWTH FACTOR; HORMONE; JANUS KINASE; STAT PROTEIN;

AUTOCRINE EFFECT; BLOOD PRESSURE REGULATION; BONE MARROW; CELL DIFFERENTIATION; CELL PROLIFERATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; PARACRINE SIGNALING; PHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHORT SURVEY; SIGNAL TRANSDUCTION; THEORY; TISSUE SPECIFICITY;

JANUS;

EID: 0343340385     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1998.0830     Document Type: Article

References (29)

1. Wilks A. F., Oates A. C. The JAK/STAT pathway. Cancer Surv. 27:1996;139-163.
2. Levy D. E. The house that JAK/STAT built. Cytokine Growth Factor Rev. 8:1997;81-90.
3. Heim M. H. The Jak-STAT pathway: specific signal transduction from the cell membrane to the nucleus. Eur J Clin Invest. 26:1996;1-12.
4. Ihle J. N., Kerr I. M. JAKs and STATs in signaling by the cytokine receptor superfamily. Trends Genet. 11:1995;69-73.
5. Weber N. R. M., Egen C., Wehinger J. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood. 88:1996;809-816.
6. Gouilleux G. V., Gouilleux F., Desaint C. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood. 87:1996;1692-1697.
7. Chakraborty A., White S. M., Schaefer T. S., Ball E. D., Dyer K. F., Tweardy D. J. Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells. Blood. 88:1996;2442-2449.
8. Minami M., Inoue M., Wei S. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc Natl Acad Sci USA. 93:1996;3963-3966.
9. Meydan N., Grunberger T., Dadi H. Inhibition of acute lymphoblastic leukemia by a JAK-2 inhibitor. Nature. 379:1996;645-648.
10. Dzau V. J. Tissue renin-angiotensin system: physiologic and pharmacologic implications. Circulation. 77:1988;I1-I3.
11. Wolny A., Clozel J. P., Rein J. Functional and biochemical analysis of angiotensin II-forming pathways in the human heart. Circ Res. 80:1997;219-227.
12. Baker K. M., Aceto J. F. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol. 259:1990;H610-H618.
13. Berk B. C., Corson M. A. Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. Circ Res. 80:1997;607-616.
14. Mrug M., Stopka T., Julian B. A., Prchal J. F., Prchal J. T. Angiotensin II stimulates proliferation of normal early erythroid progenitors. J Clin Invest. 100:1997;2310-2314.
15. Julian A. B., Gaston R. S., Barker C. V., Krystal G., Diethelm A. G., Curtis J. J. Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis. Kidney Int. 46:1994;1397-1403.
16. Conlon P. J., Smith S. R., Butterfly D. W., Brennan D. C. Losartan in post-transplant erythrocytosis. Nephrol Dialysis Transplant. 11:1996;2524-2525.
17. Nomura S., Sugihara T., Tomiyama T., Kitano Y., Yawata Y., Osawa G. Policythaemia vera: response to treatment with angiotensin converting enzyme inhibitor. Eur J Haematol. 57:1996;117-119.
18. Haznedaro ǧ I. C., Büyükaşik Y. Current evidence for the existence of a local renin-angiotensin system affecting physiologic and pathologic haemopoiesis in the bone marrow. Br J Haematol. 99:1997;471.
19. Haznedaro ǧ I. C. Angiotensin I-converting enzyme, blood groups and a local marrow-specific renin-angiotensin system. Exp Hematol. 25:1997;93.
20. Comte L., Lorgeot V., Volkov L., Allegraud A., Aldigier J. C., Praloran V. Effects of the angiotensin-converting enzyme inhibitor enalapril on blood haematopoietic progenitors and Acetyl-N-Ser-Asp-Lys-Pro concentrations. Eur J Clin Invest. 27:1997;788-790.
21. Li J., Volkov L., Comte L., Herve P., Praloran V., Charbord P. Production and consumption of the tetrapeptide AcSDKP, a negative regulator of hematopoietic stem cells, by hematopoietic microenvironmental cells. Exp Hematol. 25:1997;140-146.
22. Rousseau A., Michaud A., Chauvet M. T., Lenfant M., Corvol P. The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J Biol Chem. 270:1995;3656-3661.
23. Azizi M., Rousseau A., Ezan E. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest. 97:1996;839-844.
24. Wulf G., Jahns-Streubel G., Strutz F. Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells. Annn Hematol. 73:1996;139-141.
25. Wulf G., Jahns-Streubel G., Nobilink R., Strutz F., Hiddemann W., Wirmann B. Detection of renin-like peptide in AML blasts. Blood. 88:1996;86a.
26. Haznedaro ǧ I. C., Savas M. C., Benekli M. Renin-like activity in leukemic blast cells: an initial clue to a local renin-angiotensin system in the bone marrow. Ann Hematol. 75:1997;69-70.
27. 1receptor. Nature. 375:1995;247-250.
28. Marrero M. B., Li B., Ling B. N. Erythropoietin and angiotensin II stimulate the JAK-STAT pathway in glomerular mesangial cells. J Am Soc Nephrol. 7:1996;1682.
29. Haznedaro ǧ I. C., Tuncer S., Gürsoy M. A local renin-angiotensin system in the bone marrow. Med Hypotheses. 46:1996;507-510.